Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx by Sullu, Yurdanur et al.
Sullu et al. Diagnostic Pathology 2010, 5:35
http://www.diagnosticpathology.org/content/5/1/35
Open Access RESEARCH
© 2010 Sullu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research Poor prognostic clinicopathologic features 
correlate with VEGF expression but not with PTEN 
expression in squamous cell carcinoma of the 
larynx
Yurdanur Sullu*1, Seda Gun2, Sinan Atmaca3, Filiz Karagoz1 and Bedri Kandemir1
Abstract
Background: The aim of this study was to assess the relationship between expression of vascular endothelial growth 
factor (VEGF) and phosphatase and tensin homolog deleted in chromosome ten (PTEN), angiogenesis and 
clinicopathological parameters of squamous cell carcinoma of the larynx.
Methods: We examined immunohistochemical expression of VEGF and PTEN and CD34 for microvessel density (MVD) 
in sections of formalin-fixed, paraffin embedded tissue blocks of 140 patients with squamous cell carcinoma of the 
larynx. The intensity of VEGF and PTEN staining and the proportion of cells staining were scored.
Results: The tumor grade was not significantly related to PTEN expression, but it was to VEGF expression (p = 0.400; p 
= 0.015, respectively). While there was no significant relationship between PTEN expression and tumor size and 
cartilage invasion (p = 0.311, p = 0.128), there was a significant relationship between the severity of VEGF expression 
and tumor size (p = 0.006) and lymph node metastasis (p = 0.048) but not cartilage invasion (p = 0.129). MVD was 
significantly higher in high-grade tumors (p = 0.003) but had no significant relationship between MVD, lymph node 
metastasis, and cartilage invasion (p = 0.815, p = 0.204). There was also no significant relationship between PTEN and 
VEGF expression (p = 0.161) and between PTEN and VEGF expression and the MVD (p = 0.120 and p = 0.175, 
respectively).
Conclusions: Increased VEGF expression may play an important role in the outcome of squamous cell carcinoma of 
the larynx. PTEN expression was not related to VEGF expression and clinicopathological features of squamous cell 
carcinoma of the larynx.
Introduction
Although tumor development is a multi-stage process,
angiogenesis is essential to tumor growth and metastasis.
Angiogenesis is regulated by the balance between positive
and negative regulatory molecules released by tumor cells
and other cells in the environment. The most important
molecules positively affecting angiogenesis are basic
fibroblast growth factor, vascular endothelial growth fac-
tor (VEGF), interleukin-8 platelet-derived growth factor,
and hepatocyte growth factor. Thrombospondin 1, plate-
let factor-4, angiostatin, endostatin, IFN-α, and metallo-
proteinase tissue inhibitors are inhibitors of angiogenesis
[1]. The VEGF gene is located on the sixth chromosome.
VEGF is a heparin-binding glycoprotein with at least four
molecular forms. It enhances vascular permeability and
induces endothelial cell growth, proliferation, migration
and differentiation [2]. Phosphatase and tensin homolog
deleted in chromosome ten (PTEN) is a tumor-suppres-
sor gene located on the tenth chromosome that has a role
in the progression of the cell cycle and apoptosis. It has
been reported that PTEN inhibits angiogenesis by inacti-
vating the phosphatidilinositol 3-kinase (PI3K) signal
pathway to reduce VEGF expression [3].
The prognostic value of angiogenesis has been reported
in various tumors such as breast, gastric and ovary cancer
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[4-6]. The results of studies on VEGF expression and
tumor angiogenesis and the relationship between the
clinicopathological factors and prognosis in head and
neck tumors, particularly in squamous cell carcinoma of
the larynx, are controversial [7,8]. The effect of VEGF
expression and angiogenesis on the clinicopathological
parameters and prognosis has become more relevant
because of the use of angiogenesis inhibitors in cancer
treatment [9].
The aim of this study was to assess the relationship
between VEGF and PTEN expression and angiogenesis,
tumor differentiation, invasion and lymph node metasta-
sis in squamous cell carcinoma of the larynx.
Materials and methods
Sections from laryngectomy specimens from 140 patients
who were diagnosed with squamous cell cancer between
1989 and 2007 in Ondokuz Mayis University Faculty of
Medicine, Department of Pathology, were re-examined
and grading was performed according to WHO as well
(grade I), moderately ( grade II) and poorly (grade III) dif-
ferentiated [10]. Four micron sections were obtained
from the convenient blocks and immunohistochemical
studies were performed using PTEN (monoclonal mouse
Ab, clone 28H6, Neomarkers, CA, USA), VEGF (identify-
ing all VEGF types, polyclonal rabbit Ab, IgG, Neomark-
ers, CA, USA) and CD34 (monoclonal mouse Ab-1, clone
QBEnd/10) primary antibodies using the streptavidin
biotin peroxidase method. The best dilution rates were
recorded by various attempts. VEGF, PTEN and CD 34
were diluted at 1/100. The endogenous peroxidase activ-
ity of deparaffinized sections was eliminated by incuba-
tion for 10 min in 3% hydrogen peroxide solution. Then
the sections were boiled for 35 min in citrate buffer and
left to cool down for 20 min. Block antibodies were
applied to the sections for 5 min and VEGF, PTEN and
CD34 primary antibodies each were applied for 1 h. The
sections were then incubated with biotinylated anti-
immunglobulin and streptavidin-peroxidase conjugate
for 10 min each. A kit containing 3,3'diaminobenzidin
(DAB) (Dako, Carpinterra,, USA) was used as the color-
ing agent. Finally, the sections were stained with Mayer's
Hematoxylin for 60 min. Until DAB application, PH 7,6
phosphate buffers were used in all stages, while distilled
water was used following DAB application. The proce-
dures were performed at room temperature. As positive
controls, we used an angiosarcoma section for VEGF and
CD34, prostatic adenocarcinoma for PTEN. Negative
control slides were treated without the primary antibody.
PTEN expression was assessed by nuclear staining, and
VEGF and CD34 expressions were assessed by cytoplas-
mic staining. The extent and severity of staining were
assessed semi-quantitatively for PTEN and VEGF. The
extent of staining was classified as 0 if 0-10% of tumor
cells were stained, 1 if 11-25% of tumor cells were stained,
2 if 26-50% were stained, and staining 3 if more than 50%
were stained.
The severity of staining was classified as 1 if it was light
yellow, 2 if it was dark yellow, and 3 if it was brown. The
sum of these two classifications was scored as negative (0)
if the score was 0-2, mild (1) if the score was 3-4, and
severe if the score were 5-6. The density of micro-vessels
was calculated by averaging the number of micro-vessels
counted in four areas with intense vessels around the
tumor in ×200 magnification after visualization by ×100
magnification of CD34-stained sections [11].
Statistical analysis was performed using the "SPSS 12.0
for Windows" program. Data were expressed as mean ±
standard deviation. Sommer's D statistics were used to
evaluate the directional relation between tumor grade
and PTEN and VEGF expression. The Chi-square and
Fisher's exact test were used to compare the expression
scores of PTEN and VEGF between MVD, tumor size,
lymph node metastasis and cartilage invasion. In this test,
negative and mild positive cells were combined because
of less than 5 number cases. ANOVA test was used to
evaluate the relation between MVD and tumor grade,
expression scores of VEGF and PTEN. The level of signif-
icance was set as p < 0.05.
Results
Of the 140 cases, 3 were females and 137 were males. The
mean age was 58 ± 9.8 (range = 35-97) years. Of the cases,
76 had grade 1 squamous cell carcinoma, 41 had grade 2
and 23 had grade 3 squamous cell carcinoma. There was
no lymph node metastasis in 91 cases and there was
lymph node metastasis in 49 cases. The cartilage invasion
was positive in 71 and negative in 69 cases.
PTEN expression was negative in 26 cases (18.6%), mild
positive in 43 (30.7%), and severe positive in 71 (50.7%)
cases. VEGF expression was negative in 10 (7.1%) cases,
mild positive in 28 (20.0%), and severe positive in 102
(72.9%) cases. The tumor grade was not significantly
related to PTEN expression, but it was significantly
related to VEGF expression (p = 0.400; p = 0.015, respec-
tively) (Table 1, Figure 1 and 2).
The mean number of vessels (mean ± SEM) was 43.0 ±
2.6 in 76 cases with grade 1, 40.4 ± 2.8 in 41 cases with
grade 2, and 59.5 ± 5.8 in 23 cases with grade 3 (Figure 3).
The mean number of vessels was significantly different in
different grades (p = 0.003). Although there was no signif-
icant difference between grade 1 and grade 2 in terms of
the number of vessels (p = 0.825), there was a significant
difference between grade 1 and grade 3 and between
grade 2 and grade 3 (p = 0.007 and p = 0.04, respectively;
Table 1). There was no significant relationship between
PTEN and VEGF expression and the mean number of
vessels (p = 0.120 and p = 0.175, respectively) (Table 2).Sullu et al. Diagnostic Pathology 2010, 5:35
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While there was no significant relationship between
PTEN expression and tumor size and cartilage invasion
(p = 0.311 p = 0.128), there was a significant relationship
between PTEN expression and lymph node metastasis (p
= 0.024, chi-square = 7.479). There was a significant rela-
tionship between the severity of VEGF expression and
tumor size (p = 0.006), lymph node metastasis (p = 0.048)
but not cartilage invasion (p = 0.129) (Table 2).
There was no significant relationship between MVD,
lymph node metastasis, and cartilage invasion (p = 0.815,
p = 0.204). There was also no significant relationship
between PTEN and VEGF expression (p = 0.161).
Discussion
Angiogenesis is an essential process in the growth of the
primary tumor and the development of metastasis [1].
VEGF plays a key role in tumor angiogenesis and it has
been identified in many malignancies, including head and
neck squamous cell carcinoma [2,7,12,13]. However, a
number of different factors can regulate VEGF expression
including hypoxia, cytokines, oncogenes and tumor sup-
pressor genes [14]. PTEN, a tumor suppressor gene, is a
PI3K antagonist. PI3K has a role in many cellular events
such as cell proliferation and survival, protein synthesis
and tumor growth. PI3K and Akt have a role in tumor
growth and angiogenesis by regulating VEGF and
hypoxia-inducible factor-1 expression [3]. Our results
showed that there was no correlation between PTEN
expression and VEGF expression which has not been
investigated in the previous studies of the squamous cell
carcinoma of the larynx. Also there was not a significant
relationship between PTEN expression and tumor grade,
tumor size and cartilage invasion in the laryngeal
squamous cell carcinoma. This study demonstrates that
VEGF expression is closely related to the poor clinico-
pathologic features including tumor grade, tumor size
Table 1: Association of VEGF, PTEN expression and MVD with tumor grade in laryngeal carcinoma (mean ± standard error 
of mean).
PTEN VEGF
N(%) Negative Mild Severe P Negative Mild Severe P MVD* P
Grade 0.400 0.015 0.003
Grade 1 76 11(14) 27(36) 38(50) 7(9) 18(24) 51(67) 43.0 ± 2.6
Grade 2 41 6(15) 11(27) 24(58) 2(5) 10(24) 29(71) 40.4 ± 2.8
Grade 3 23 9(39) 5(22) 9(39) 1(4) 22(96) 59.5 ± 5.8
Total (%) 140 26(18) 43(31) 71(51) 10(7) 28(20) 102(73)
*p: grade 1 vs 3 = 0.007; grade 2 vs 3 = 0.04; MVD, microvessel density; PTEN, phosphatase and tensin homolog deleted in chromosome ten; VEGF, 
vascular endothelial growth factor;
Figure 1 Immunohistochemical demonstration of PTEN expres-
sion in grade 2 laryngeal squamous cell carcinoma, (severe, score 
6) ×400.
Figure 2 Immunohistochemical demonstration of VEGF expres-
sion in grade 2 laryngeal squamous cell carcinoma, (mild, score 4) 
×200.Sullu et al. Diagnostic Pathology 2010, 5:35
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and lymph node metastasis of laryngeal squamous cell
carcinoma.
After the first demonstration of the prognostic value of
tumor angiogenesis in 1988 in malignant melanoma,
VEGF expression has been studied in various tumor. The
relationship of VEGF expression with parameters such as
tumor differentiation, lymph node metastasis, and inva-
sion depth has been reported in various tumors
[12,13,15,16]. The findings of studies assessing the rela-
tionship between VEGF expression and tumor differenti-
ation, stage, and lymph node metastasis differ in head and
neck carcinomas [13,17,18]. In a study reporting that
there was no relationship between VEGF expression and
tumor grade and localization in head and neck epider-
moid carcinomas, it was reported that there was a corre-
lation between increased VEGF expression and
shortened life span [19]. In a series of head and neck epi-
dermoid carcinomas with only nine cases of laryngeal
carcinoma, there was no relationship between VEGF
expression and histological grade and lymph node metas-
tasis but VEGF expression was correlated with life span,
especially in tumors of the larynx and the oral cavity [18].
Tae et al. [8] reported that there was no correlation
between VEGF expression and tumor differentiation,
stage, and localization in carcinomas of the head and
neck region. They also stated that VEGF expression was
at higher levels in benign lesions than in dysplasias and
carcinomas, and suggested that VEGF may be effective in
regulating the mucosa functions in normal physiological
conditions. Unlike our study and other studies, VEGF
e x p r e s s i o n  w a s  a t  h i g h e r  l e v e l s  i n  t h e  g r o u p  w i t h o u t
lymph node metastasis in this study [8]. The finding in
our study that there was a significant relationship
between VEGF expression and tumor differentiation,
size, and lymph node metastasis supports the association
of increased VEGF expression with invasive and aggres-
sive forms of laryngeal tumors. The reasons for the differ-
ent findings in our study may be the differences in
assessment of VEGF expression and the fact that the
other studies included tumors with different localizations
in the head and neck region.
The relationship between MVD and prognostic param-
eters in head and neck epidermoid carcinoma could not
be completely explained [20]. In spite of studies finding a
relationship between high MVD and tumor progression,
tumor stage and grade, studies suggesting that there was
no such relationship have also been reported [7,8,12,20-
Table 2: Association of PTEN and VEGF expression and pathological features of laryngeal carcinoma (mean ± standard 
error of mean).
PTEN VEGF
N(%) Negative
26
Mild
43
Severe
71
pN e g a t i v e
10
Mild
28
Severe
102
p
MVD 140 51.9 ± 5.9 46.7 ± 3.6 41.3 ± 2.3 0.120 32.0 ± 6.3 44.4 ± 4.4 46.4 ± 2.3 0.175
Tumor size (mm) 3.1 ± 0.2 2.8 ± 0.2 3.2 ± 0.1 0.311 1.9 ± 0.2 3.1 ± 0.2 3.1 ± 0.1 0.0006
Lymph node 0.024 0.048*
No 91 18(20) 34(37) 39(43) 10(11) 20(22) 61(67)
Yes 49 7(14) 9(19) 33(67) 0 8(16) 41(84)
Cartilage invasion 0.128 0.129*
No 69 15(22) 25(36) 29(42) 10(14) 13(19) 46(67)
Yes 71 11(16) 18(25) 42(59) 0 15(21) 56(79)
*: Mild and negative cells were combined in VEGF line because of less than 5 in some cells (Fisher's exact test). MVD, microvessel density; PTEN, 
phosphatase and tensin homolog deleted in chromosome ten; VEGF, vascular endothelial growth factor.
Figure 3 Immunohistochemical demonstration of microvessels 
with anti-CD34 in grade 2 laryngeal squamous cell carcinoma, 
(density of microvessel counted as 43) ×200.Sullu et al. Diagnostic Pathology 2010, 5:35
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22]. Tse et al. [19] conducted a study on 186 cases with
head and neck epidermoid carcinomas including 34 cases
with laryngeal carcinoma. They reported that there was
no relationship between MVD and tumor stage, grade,
localization, metastasis or prognosis. It was reported in
this study that VEGF was strongly expressed but there
was no relationship between VEGF expression and MVD
in head and neck epidermoid carcinomas. MVD assess-
ment was performed by two different methods by select-
ing hot-spot and random sites based on the fact that
epidermoid carcinoma was poor for stroma and had little
vascular proliferation and hot-spot sites could not be
selected properly. It was reported in two assessments that
there was no relationship between MVD and VEGF
expression and clinicopathologic parameters. Kyzas et al.
[18] reported that there was no relationship between
MVD and tumor grade, localization and lymph node
metastasis in 69 cases with head and neck epidermoid
carcinoma, and although they found a tendency of
increase in MVD with the increased VEGF expression,
this increase was not significant. In this study it was
reported that they performed with CD31 and CD34 and
that the correlation between VEGF expression and MVD
was weaker when CD34 was used [18]. The increased
MVD in less differentiated tumors in our study suggested
that the increase in MVD may be related to loss of differ-
entiation. There may be several reasons why we did not
find a relationship between VEGF expression and MVD.
VEGF expression is only one of the angiogenic factors.
Many molecules such as angiogenin, interleukin 8 and 10,
platelet-derived endothelial growth factor, fibroblast
growth factor, and angiopoetins have a role in tumor
angiogenesis [23]. Besides forming new vessel buds,
V E G F  i s  a l s o  u s e d  a s  a n  a u t o c r i n e  g r o w t h  f a c t o r  f o r
tumor cells. The presence of VEGF receptors on tumor
cells in head and neck epidermoid carcinomas has been
demonstrated [8]. Besides, it is known that other cellular
elements such as macrophages and fibroblasts express
V E G F  a t  v a r i o u s  l e v e l s  [ 2 3 ] .  T h i s  p o i n t  o f  v i e w  m a y
explain the lack of a significant correlation between
VEGF expression and MVD. Another reason for the dis-
crepancy between VEGF expression and MVD and
between MVD and the other parameters may be the lack
of a direct method to demonstrate angiogenesis [24]. The
conventional antibodies used to show vessels are not spe-
cific to active angiogenic vessels [19]. It has been reported
that using antibodies that show endothelial cell prolifera-
tion to assess tumor vascularization would be beneficial
[24]. The lack of a significant relationship between VEGF
expression and MVD shows that tumor angiogenesis is a
complex process [23].
In addition to extracellular signals such as growth fac-
tors, the activation of oncogenes or the mutations of
tumor suppressor genes such as PTEN and p53 trigger
tumor angiogenesis. PTEN mutations were reported in
ovarian, brain, breast, thyroid, endometrium and stom-
ach tumors [25-28]. The relationship between PTEN
expression and tumor differentiation, lymph node metas-
tasis, and invasion depth has been reported in tumors of
the brain, prostate, breast, and stomach [26,28,29]. While
the loss of PTEN expression has been found to be corre-
lated with the loss of differentiation in tumors of the oral
cavity, it has also been reported that there was no signifi-
cant relationship between PTEN expression and the
tumor stage, differentiation, lymph node metastasis in
laryngeal carcinoma [30]. Squarize et al. [31] found a neg-
ative relationship between PTEN expression and the
grade in oral squamous cell carcinomas and reported that
PTEN was an independent prognostic factor. In a study
reporting that there was a decrease in PTEN expression
in laryngeal tumors, there was no relationship between
PTEN expression and tumor localization, tumor size, dif-
ferentiation and stage [32]. We could not find a correla-
tion between PTEN expression and tumor size,
differentiation, lymph node metastasis and invasion
depth. The relationship between PTEN expression and
lymph node metastasis was the opposite of the expected;
therefore, further studies are required on this topic.
The relationship between PTEN and angiogenesis has
bee n  e x p l a i n ed  b y  PT E N  be i n g  a  P I 3 K  a n t a g o n i s t  a n d
therefore inhibiting angiogenesis [3]. It has been reported
that the decrease in PTEN expression was correlated with
VEGF expression and MVD increase in gastric and colon
tumors [16,33]. Chung et al. [34] reported in their study
with invasive ductal carcinoma that there was no rela-
tionship between PTEN expression and VEGF expression
and MVD. Similarly we were not found significantly cor-
relation between PTEN and VEGF expression and MVD.
Further studies are needed to clearly explain the relation-
ship between PTEN expression and angiogenesis.
In conclusion, VEGF expression was found to be corre-
lated with grade, tumor size and lymph node metastasis
in laryngeal tumors. However there was no correlation
between PTEN expression and poor prognostic clinico-
pathologic factors. Increased VEGF expression may be
useful to choose patients who are candidates for anti-
VEGF treatment [35]. The lack of significant association
between PTEN expression, VEGF expression and MVD
indicates that to reveal the complex phenomenon of
tumor angiogenesis in the laryngeal squamous cell carci-
noma further investigation is needed.
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